Bayerische Motoren Werke Aktiengesellschaft

2020 (Mar – Dec)

COVID-19 forced shutdowns of BMW plants in Europe and Rosslyn (South Africa) from March through April, with production pauses extended as demand collapsed and operations were curtailed [12,21,22,23,24,25]. Mid-year, management cut the proposed FY2020 dividend and did not renew roughly 10,000 contract roles as capacity was adjusted [15,17,18].

The initial pandemic shock gave way to a reassessment of BMW as a resilient premium cyclical. The market viewed the company as better positioned than many peers due to brand and pricing power [15,22]. A sharp market crash in March was followed by pronounced recovery through the second half of 2020. The shares finished the year materially recovered relative to the DAX, establishing a base for the 2021 uptrend [15,25].

2021

A persistent global semiconductor shortage constrained output throughout the year. BMW reported it could not finish roughly 10,000 cars at one point, with production shortfalls continuing to force shift-scheduling and selective prioritisation of higher-margin models [28,27,30,31].

Despite these constraints, BMW posted record full-year results with 2021 deliveries of approximately 2.52 million units, net profit surged, and margins strengthened through pricing and mix. BEV and PHEV volumes grew rapidly, more than doubling in 2021 [42,51,36,32,34].

The narrative shifted from "COVID recovery" to "premium OEM with pricing power and relatively good supply-chain management." Investors increasingly framed BMW as a premium cyclical capable of protecting margins via mix and price rather than pure volume growth [36,42,51]. The year showed a broad uptrend with episodic volatility tied to chip-shortage headlines and production updates; positive earnings surprises and the EV narrative produced rallies and re-ratings [36,34].

2022

On 11 February, BMW acquired an additional stake in its Chinese joint venture BMW Brilliance Automotive (BBA) to hold 75%, with BBA fully consolidated from that date. BMW disclosed a preliminary one-off revaluation benefit of approximately €7–8 billion and a cash-flow consolidation effect of roughly €5 billion, which materially changed reported Group figures for 2022 [57,59,66].

The Russia–Ukraine war in March increased supply and energy uncertainty. BMW revised automotive segment margin guidance downward due to new supply and cost risks [46,32]. Later in the year, investor concern surfaced after forensic and financial issues were reported around Brilliance's parent, adding partner and China governance risk to the story [65,69].

The narrative bifurcated: the BBA consolidation was seen as strategically positive in terms of control and scale in China but also as an accounting or one-off boost rather than pure operational improvement. Geopolitical and partner-governance headlines introduced caution, shifting the narrative to "China-scale growth story but with execution and partner risk" [57,65,69]. A temporary uplift in reported earnings from the accounting effect supported the stock briefly in February and March; from spring onward, price action was volatile and rangebound as investors balanced consolidation benefits against macro and partner risks [57,46,65].

2023

BMW confirmed solid business figures for 2022 and strategy execution. Group earnings before tax and net profit rose, deliveries remained strong (slightly down versus 2021), and electrified vehicles reached materially higher shares of volume at 18.1% in 2022; order books stayed robust [47,63].

The narrative continued to evolve toward "electrification leader among premium OEMs" combined with recognition of cyclicality and China exposure. Investors increasingly priced BMW as a hybrid of quality auto earnings and EV growth optionality [47,63]. The year was strong for the stock with significant positive total return; price action generally trended higher as earnings quality and EV momentum were confirmed, marking a clear recovery and re-rating phase against 2021–2022 volatility [1,47].

2024 – 2025

The market repriced and pulled back in 2024, with annual performance data showing a correction. In 2025, a strong rebound and re-rating followed, with 2025 recording a large positive return of 42.64% and price reaching multi-year end-of-day highs in late 2025, with the highest end-of-day level noted on 9 December 2025 [1].

Perception swung from "risk and repricing" to "re-rated cyclical and EV execution" as fundamentals and investor appetite improved. By late 2025, investors had re-embraced BMW both as a premium cyclical recovery play and an EV execution story [1,47]. Technically, 2024 represented a corrective phase and breakdown from prior ranges, while 2025 delivered a powerful bull leg and breakout to multi-year highs, followed by topping pressure into late 2025 and early 2026 as momentum faded [1,4].

H1 2026 (Jan – 30 Jun)

A large, rapid correction unfolded in the first half of 2026. Price moved from roughly €90–96 in early January to approximately €80 by March, then collapsed into the low 60s and 50s by late June, reaching €57.26 by 30 June [4,3,8,5].

No single contemporaneous company announcement in available sources explains the fall. The most likely proximate drivers were macro risk-off sentiment, profit-taking after the 2025 re-rating, renewed concerns on cyclical demand and China softness, and margin and earnings sensitivity to rates and costs [1,57,65].

The narrative shifted quickly from "re-rated EV and cyclical recovery" to "de-rating, earnings sensitivity, and value-trap risk" as investors reassessed cyclicality and China exposure. The sell-off implied rotation away from cyclical autos and into defensives, AI, and energy [1,57,65].

Technically, the move in H1 2026 is an unusually large and fast drawdown of roughly 50% or more from the late-2025 peak to €57.26 at end-June. This represents a loss of multi-month support established in 2021–2023, a steep breakdown with high volatility and no long consolidation at the new lows—the pattern of a forced, fast de-risking phase rather than a slow grinding decline [1,4,3,5].